We demonstrated that the DNA methyltransferase inhibitor, decitabine, ameliorates bone loss in a mouse model of periodontitis via a mechanism that involves the regulation of anti-inflammatory cytokine expression by KLF2. This evidence concerns the gene KLF2 and periodontitis.